KELLY HYDER: Open Payments
NPI 1245798107 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,687 in 106 payments from 40 companies in 2025. Trend: 2023 $223 · 2024 $155 · 2025 $2,687
Food & beverage: $2,225Education: $462
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $278 |
| Janssen Biotech, Inc. | 8 | $257 |
| Merck Sharp & Dohme LLC | 7 | $176 |
| Novartis Pharmaceuticals Corporation | 10 | $152 |
| Astellas Pharma US Inc | 3 | $149 |
| Incyte Corporation | 3 | $145 |
| ABBVIE INC. | 3 | $120 |
| Daiichi Sankyo Inc. | 4 | $94 |
| E.R. Squibb & Sons, L.L.C. | 4 | $86 |
| Genentech USA, Inc. | 5 | $85 |
Products named: ERLEADA, KEYTRUDA, IMBRUVICA, ENHERTU, Nubeqa, KISQALI, Optune Lua (NovoTTF-200T), VERZENIO.
Industry payments across TN — which companies pay providers there.
